What does Cybozu do?
Cybozu provides cloud software that helps companies run internal communication and daily operations. Cybozu Office and Garoon are groupware products used for scheduling, workflow, and internal coordination. kintone is a no-code platform that lets business teams build and run internal apps without writing software, and revenue per customer rises as usage expands and accounts move to higher plans. The investor debate now centers on whether kintone ARPA can keep rising, how clearly management defines capital discipline for US investment, and whether buybacks and broader capital policy become a continuing framework.
What has driven the stock over the past two years?
Cybozu shares rose from around ¥1,600 in May 2024 to ¥4,150 in August 2025, then gave back most of that move over the next eight months. There were three turning points: FY12/26 guidance in December 2025, the US-subsidiary impairment in February 2026, and the 1Q result plus ¥3.0bn buyback announced after the close on May 14, 2026.
01 · THE RALLY Cybozu is a Japanese software company that, for most of its 28-year history, was known domestically as the maker of two groupware products — Cybozu Office for small and mid-size businesses and Garoon for larger organizations. Both ran for years as packaged on-premise software and gradually migrated to a subscription model on Cybozu's own cloud platform, cybozu.com. What changed the equity story was the platform's third application, launched in 2011: kintone, a no-code environment in which a non-technical employee inside a customer company can assemble database-backed business applications without writing software. kintone is the structural growth engine. By December 2025 it had been adopted by approximately 39,000 Japanese companies (37,000 a year earlier), and adopted by about 46% of TSE Prime companies. Roughly two-thirds of domestic cloud revenue is routed through a network of about 560 partner firms, which carry out implementation and configuration work on the customer's behalf — meaning Cybozu sells software while its partners sell services. The model carries structurally lower service-and-support cost than US-listed SaaS peers (Atlassian, monday.com, Asana) which staff their own implementation teams. Inside the installed base, kintone seats grow without further sales effort — the FY12/25 net revenue retention rate was 121.9% on existing customers alone, against monthly gross-revenue churn under 1%. From roughly ¥1,600 in May 2024 the stock climbed steadily as that compounding became visible in successive filings, broke through ¥3,000 over the winter on FY12/24 results that showed revenue up 16.7% YoY and operating profit (OP) up 44.1% YoY, and continued through the 1H of 2025. The pivotal disclosure came earlier in the period: a price revision and a minimum-user-count contract floor through FY12/24 and FY12/25 lifted kintone's average revenue per account from ¥34,100 in FY12/23 to ¥47,100 in FY12/25 — a 38% step-up over two years. When 1H FY12/25 results landed in August 2025 the operating-leverage consequences were unmistakable: the full year would close with revenue up 26.1% YoY and OP up 106.4% YoY, a margin print that turned the ARPA story into a P&L event. The stock peaked at ¥4,150 on August 19, 2025, implying roughly thirty times forward EV/OP — the market underwriting FY12/25 as the new run-rate rather than a single year of windfall.
02 · THE REVERSAL The reversal began on December 18, 2025, when Cybozu published its initial guidance for FY12/26. Revenue was guided at +12.7% and OP at +4.1% — a collapse from the +106% just printed. Management framed the slower profit growth as a deliberate cost-base step-up tied to its longer-term FY12/28 ¥50.9bn revenue target: a special bonus paid through to employees, a planned material increase in advertising and R&D (which 1Q FY12/26 would print as +28% and +34% YoY respectively), plus the operating cost of newly consolidating Ehime Sports Entertainment, the regional B-League basketball franchise in which Cybozu had taken a 50.15% stake earlier in the year. The deeper question the disclosure raised, however, was structural: had the FY24/FY12/25 ARPA step from ¥34,100 in FY12/23 to ¥47,100 in FY12/25 been a repeatable pricing lever, or a one-time event the company had already absorbed? The 52% ARPA jump had not been decomposed by management between price-revision effect, seat expansion within existing customers, and tier-mix shift toward kintone's enterprise-grade Wide Course. With marketing intensity now planned to rise faster than revenue, the risk that the share of new revenue Cybozu was converting to OP (67% in FY12/25) would not hold up began to be priced. A second disclosure compounded the first. On February 10, 2026 Cybozu booked a ¥1,485M non-consolidated impairment on its equity stake in Kintone Corporation, the US subsidiary it had operated since August 2011 (renamed from CYBOZU CORPORATION in 2016). The sub finished FY12/25 ¥355M underwater on a net-asset basis; management explicitly retained the US growth thesis and signaled continued funding. For investors the impairment forced the cumulative-capital question (likely above ¥10bn over the arc since 2011) and made the absence of a published payback timeline or exit trigger newly visible. By April 13, 2026 the share had walked down to ¥1,965 — a 53% drawdown from the August peak.
03 · WHERE WE STAND NOW Two disclosures landed after the market close on May 14, 2026. The 1Q FY12/26 tanshin printed revenue ¥10,246M (+17.0% YoY), OP ¥3,014M (+15.3% YoY), and net income ¥2,191M (+21.6% YoY). The 15% OP growth was achieved at the higher cost base the FY12/26 plan had already embedded: ad spend up 28% in the quarter, R&D up 34%, with Ehime Sports operating cost now consolidated in cost of sales. The 1Q OP margin of 29.4% sat 4.5ppt above the FY12/26 full-year guide of 24.9%, and the progress ratios — 24% of the revenue plan (in line with Cybozu's 23–24% historical 1Q revenue share) and 29% of the OP plan (at or above the FY24/FY12/25 1Q OP share of 25–27%) — implied the +4.1% guide was a conservative anchor rather than the structural run-rate. The same disclosure window carried a second item: the board authorized a ¥3.0bn buyback for up to 3.0M shares, equivalent to 6.5% of shares outstanding — matching the ¥3.0bn / 3.0M-share program of September 2024 (6.5% of shares outstanding ex-treasury vs 6.3% then) — the two biggest repurchase programs authorized since the 2000 listing on TSE Mothers; ¥2.9bn of the 2024 program was executed. Combined with the FY12/26 DPS of ¥50 (a 25% YoY increase, equivalent to approximately ¥2.3bn on the 46.2M shares outstanding ex-treasury), the announced FY12/26 capital-return floor sits at roughly ¥5.3bn — about 71% of forecast net income. The operating-business quality has not deteriorated through the drawdown: trailing ROCE on averaged capital employed remains 68%, free-cash-flow yield at the current share price is around 8%, group OP margin is 27%. What the next four quarters resolve is whether the FY12/25 ARPA step compounds at the new cost base, whether the US subsidiary returns to investment justifiability, and whether the May 14 buyback marks the start of a stated capital-return framework or a single discretionary event.
What has to be verified next?
Three open questions surface in the company's recent quarterly disclosures and in the IR briefing Q&A. Each one settles a different part of the multiple.
What could change over the next twelve months?
Three disclosure or capital-policy levers visible in the filings. Each could reweight the multiple without requiring higher earnings.
JII scenario framework for the next four quarters
These are JII analytical scenarios, not company guidance and not price predictions. They map valuation states to observable operating assumptions.
- FY12/26 OP lands at or below the ¥10.5bn guide — operating leverage does not re-establish at the higher cost base.
- A second non-consolidated impairment of Kintone Corporation at FY12/26 results.
- An Ehime arena commitment of ≥¥3 billion funded from Cybozu's own balance sheet without bringing in outside investors (REIT, regional bank, naming-rights sponsor) or separating the sports business from the SaaS business.
- No ARPA decomposition disclosure; no second buyback or formal capital-return framework.
- Domestic kintone NRR slipping below 115% as price-revision-driven seat expansion runs off.
The bear band of ¥1,500–¥1,800 implies ~5.8–7.0x forward EV/OP — below the 7–10x range typical of JP private-buyer transactions. The bear is multiple-driven only if the market continues to discount pricing-power durability beyond what a strategic buyer would.
- A 2Q or 3Q FY12/26 guidance upgrade to full-year OP ≥¥11bn.
- kintone ARPA trajectory disclosed at mid-year or full-year results, separating durable lever from spent.
- The ¥3bn buyback completes within the May 15–July 31 window; FY12/26 results acknowledge a second authorization or a sustainable framework.
- No further Kintone Corp impairment; US revenue growth ≥30% YoY (first disclosure of the line itself is base case).
- ARPA decomposition disclosure shows the durable seat/tier lever compounds at high single-digits independent of further price action.
- A formal capital-allocation framework — total-return floor of X% of net income annually with formula-based buyback gate.
- Kintone Corp committed-capital disclosure with a credible breakeven milestone (regardless of direction — the disclosure itself is the catalyst).
- FY12/26 OP lands at ≥¥11.5bn (10% above guide), confirming leverage re-establishes at the higher cost base.
- Ehime arena, if announced, financed by outside investors (REIT, regional bank, naming-rights sponsor) and structured so the sports business sits separately from the SaaS business that drives Cybozu's value.
The bull peak of ¥4,000 stays below the August 2025 high of ¥4,150 — the framework does not embed a return to the peak ~30x forward EV/OP multiple, which would require both ARPA re-acceleration and the US/APAC business turning a structural corner, two-stage optionality outside this four-quarter scenario.
This is not investment advice.
Japan Investor Interface Co., Ltd. ("JII") is an investor-relations (IR) consultancy. JII is not a registered investment advisor, financial advisor, broker-dealer, or securities firm in any jurisdiction. JII is not registered as a Financial Instruments Business Operator (金融商品取引業者) under Japan's Financial Instruments and Exchange Act. JII does not have a 投資助言・代理業 registration and does not provide investment advice or solicit the purchase, sale, or holding of any security.
JII Compounders is an editorial publication. Each profile is an analytical study of how publicly disclosed information about a Japanese listed company has been received by the market. It is intended for educational and research purposes for IR professionals, finance students, journalists, and other readers interested in corporate disclosure practice. Nothing in this publication constitutes a recommendation, opinion, suggestion, or solicitation to buy, sell, or hold any security, derivative, or other financial instrument. Price targets, scenario ranges, multiples, and comparable-company references are illustrative of analytical method only and must not be interpreted as JII's investment opinion. JII does not have an investment opinion on any security discussed.
No reliance. The information presented may be incomplete, out of date, or incorrect. Forward-looking statements are inherently uncertain. Past price performance does not indicate future results. Estimates and scenario figures are not predictions and may not be achieved. JII makes no representation or warranty, express or implied, regarding the accuracy, completeness, timeliness, or reliability of any information in this publication.
No fiduciary or advisory relationship. Reading this publication does not create any advisory, fiduciary, or professional relationship between you and JII. Before making any investment, tax, accounting, legal, or other decision, you should consult qualified, licensed advisors in your jurisdiction and conduct your own independent due diligence based on primary disclosures issued by the company concerned.
Conflicts & positions. JII may provide paid IR diagnostic, translation, or interpretation services to Japanese listed companies, including companies discussed in this publication. JII does not trade in or hold positions in the securities of companies profiled. Where a JII engagement exists with a profiled company, that fact will be disclosed at the top of the profile.
Trademarks & data. Company names, logos, tickers, and product names referenced are the property of their respective owners. Share-price data is licensed from third-party providers. TradingView is a trademark of TradingView, Inc. All rights reserved.
本資料は、日本の金融商品取引法に基づく投資助言・代理業ではなく、特定の有価証券の売買その他の取引の勧誘・推奨を目的とするものではありません。本資料は教育・研究を目的とした分析記事であり、JII（株式会社ジャパン・インベスター・インターフェース）は、本資料の内容に基づく投資判断について一切の責任を負いません。投資の判断はご自身の責任と独立した調査に基づいて行ってください。